Amyris announces pricing of a $300.0 million public offering (secondary and primary) of common stock

Emeryville, calif., april 9, 2021 /prnewswire/ -- amyris, inc. (nasdaq: amrs) ("amyris"), a leading synthetic biotechnology company active in the clean health and beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of 11,390,797 shares to be sold, in the aggregate, by dsm international b.v.
AMRS Ratings Summary
AMRS Quant Ranking